Medacta Group SA
LSE:0A05

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
LSE:0A05
Watchlist
Price: 133.6097 CHF -2.9% Market Closed
Market Cap: CHf2.7B

Wall St Price Targets

0A05 Price Targets Summary
Medacta Group SA

Wall Street analysts forecast 0A05 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0A05 is 168.9772 CHF with a low forecast of 149.2786 CHF and a high forecast of 190.1342 CHF.

Lowest Forecast
Price Target
149.2786 CHF
12% Upside
Average Forecast
Price Target
168.9772 CHF
26% Upside
Highest Forecast
Price Target
190.1342 CHF
42% Upside
Medacta Group SA Competitors:
Price Targets
SITM
SiTime Corp
56% Upside

Revenue
Forecast

14% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
14% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 7 years is 10%.

Gross Profit
Forecast

12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 8 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 13%.

Operating Income
Forecast

11% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
11% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 8 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 7 years is 11%.

Pre-Tax Income
Forecast

12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
12% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 13%.

Net Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 8 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0A05's stock price target?
Price Target
168.9772 CHF

According to Wall Street analysts, the average 1-year price target for 0A05 is 168.9772 CHF with a low forecast of 149.2786 CHF and a high forecast of 190.1342 CHF.

What is the Revenue forecast for Medacta Group SA?
Projected CAGR
10%

Over the last 8 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 7 years is 10%.

What is the Gross Profit forecast for Medacta Group SA?
Projected CAGR
13%

Over the last 8 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 13%.

What is the Operating Income forecast for Medacta Group SA?
Projected CAGR
11%

Over the last 8 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 7 years is 11%.

What is the Pre-Tax Income forecast for Medacta Group SA?
Projected CAGR
13%

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 13%.

What is the Net Income forecast for Medacta Group SA?
Projected CAGR
11%

Over the last 8 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett